Fortrea Clinical Research Unit Inc. - Madison

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Obesity5 trials
• Atopic dermatitis (eczema)2 trials

Phase

• Phase 17 trials

Status

• Completed4 trials
• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Amgen6 trials
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)

  NCT07908316· Phase 1· Amgen· Source

• Active, not recruiting

  Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity

  NCT07523711· Phase 1· Amgen· Source

• Active, not recruiting

  A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

  NCT07476118· Phase 1· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting

Closed trials

• Completed

  Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

  NCT07226778· Phase 1· Amgen· Source

• Completed

  A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity

  NCT07717814· Phase 1· Amgen· Source

• Completed

  A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

  NCT06438263· Phase 1· Amgen· Source

• Completed

  A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

  NCT06268860· Phase 1· Amgen· Source